Increasing knowledge on the relevance of factors other than morphological criteria with respect to prediction of HCC recurrence, such as alpha-fetoprotein concentration, inflammatory markers, and response to neoadjuvant therapies, has enabled changes in selection policy towards moderate liberalization [12,13,14,15,16,17]. Here, AFP is linked to hepatocellular carcinoma.